se of botulinum toxin a to manage upper limb spasticity in children with cerebral palsy

Not Applicable

Completed

• Conditions: spasticity; cerebral palsy; botulinum toxin A; strength training; Neurological - Other neurological disorders

• Registration Number: ACTRN12607000486426
• Lead Sponsor: Princess Margaret Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age
hemiplegia due to cerebral palsy
spasticity

Exclusion Criteria

unable to complete all testing

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Melbourne Assessment of Unilateral Upper Limb Function[baseline, 6 weeks, 3 months and 6 months after randomisation]

Secondary Outcome Measures

Name	Time	Method
jerk analysis[baseline, 6 weeks, 3 months and 6 months after randomisation];Mapping of corticor motor pathways using transccranial magnetic stimuation[baseline, 6 weeks, 3 months and 6 months afetr randomisation]